26 /100
MEDIUM RISK
Score updated Jul 14, 2026

OLMA — Olema Pharmaceuticals, Inc. Dilution Risk Tracker

Track OLMA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OLMA — Get alerts when the score changes →

As of July 14, 2026, Olema Pharmaceuticals, Inc. (OLMA) has a DilutionWatch DilutionScore of 26/100, rated MEDIUM dilution risk. Olema Pharmaceuticals, Inc. has a market capitalization of $1.15B, 87.35M shares outstanding, 202 institutional holders tracked. Key dilution vectors include approximately 45 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for OLMA.
🔔 Track OLMA — Get forecast alerts →

💹 Market Data

Market Cap$1.15B
Shares Outstanding87.35M
Float59.72M
Cash$505.35M
Debt$3.96M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 30.1% shares (2026Q1 vs prior)
202 institutional holders · 121.67M shares
#1 JANUS HENDERSON GROUP PLC 14.22M shares
#2 FMR LLC 10.39M shares
#3 Paradigm Biocapital Advisors LP 8.02M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest14.03M
Days to Cover5.7
% of Float23.5%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2020
4 INSIDER TRANSACTION Apr 29, 2026
3 FORM3 Apr 29, 2026
4 INSIDER TRANSACTION Mar 05, 2026
3 FORM3 Feb 17, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for OLMA Shareholders

Olema Pharmaceuticals, Inc. (OLMA) has a DilutionScore of 26/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for OLMA shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for OLMA in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for OLMA alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track OLMA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking OLMA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for OLMA
📊 OLMA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 OLMA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.